Get the Stockscreener App
15.20
0.14%
0.0215
Kraneshares Msci All China Health Care Index Etf stock is traded at $15.20, with a volume of 22,812.
It is up +0.14% in the last 24 hours and down -6.92% over the past month.
See More
Previous Close:
$15.18
Open:
$15.17
24h Volume:
22,812
Relative Volume:
1.14
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.18%
1M Performance:
-6.92%
6M Performance:
-16.30%
1Y Performance:
-13.93%
1-Day Range:
$15.04
$15.43
1-Week Range:
$14.38
$15.43
52-Week Range:
$14.38
$21.88
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Company Profile
Name
Kraneshares Msci All China Health Care Index Etf
Sector
Industry
Phone
-
Address
-
Compare KURE vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURE
Kraneshares Msci All China Health Care Index Etf
|
15.20 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
372.53 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
754.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
756.35 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
298.44 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
744.00 | 124.43B | 0 | 0 | 0 | 0.00 |
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Latest News
Healthcare ETF: Outbound Biotech Licensing As Potential New Growth Driver In China - KraneShares
KURE ETF Holdings List — BIVA:KURE - TradingView
KURE ETF Analysis: Dividends, Returns BIVA:KURE - TradingView
KURE Stock Fund Price and Chart — BIVA:KURE - TradingView
Why Is KraneShares MSCI All China Health Care Index ETF (KURE) Stock Up Today? - Meyka
ETFs Investing in Sino Biopharmaceutical Limited Stocks - TradingView
How Kraneshares Msci All China Health Care Index Etf (KURE) Affects Rotational Strategy Timing - Stock Traders Daily
(KURE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
ETFs Investing in BeOne Medicines Ltd. Stocks - TradingView
Responsive Playbooks and the KURE Inflection - Stock Traders Daily
ETFs Investing in Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A Stocks - TradingView
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs Investing in XtalPi Holdings Limited Stocks - TradingView
Understanding the Setup: (KURE) and Scalable Risk - Stock Traders Daily
The Technical Signals Behind (KURE) That Institutions Follow - Stock Traders Daily
Accessing Chinese Health Care Companies - stockinvestor.com
Precision Trading with Kraneshares Msci All China Health Care Index Etf (KURE) Risk Zones - Stock Traders Daily
Stock List: Research Stocks from Around the World - GuruFocus
KURE, EEMA, CHIH: Chinese Healthcare ETFs Have the Potential for Big Gains - TipRanks
Technical Reactions to KURE Trends in Macro Strategies - Stock Traders Daily
Trading the Move, Not the Narrative: (KURE) Edition - news.stocktradersdaily.com
China ETF News: Retail Sales Beat Estimates - Seeking Alpha
KURE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
(KURE) Volatility Zones as Tactical Triggers - Stock Traders Daily
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs - TipRanks
Price-Driven Insight from (KURE) for Rule-Based Strategy - Stock Traders Daily
KURE, EEMA, CHIH: Get Exposure to Chinese Technology Through Healthcare ETFs - TipRanks
(KURE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
China ETFs: A Comprehensive Guide On How To Invest In China - KraneShares
(KURE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
(KURE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Beyond U.S. Tech Stocks — Top Asia AI Opportunities for 2026 - TheStreet Pro
KraneShares TrustKraneShares MSCI All China Health Care Index ETF announces Annual dividend, payable on December 23, 2025 - MarketScreener
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
5 Biggest Pharmaceutical ETFs in 2025 - Nasdaq
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermedia - Benzinga
KURE - KraneShares
KCAI - KraneShares
KEMX - KraneShares
KBA - KraneShares
KraneShares MSCI All China Health Care Index ETF Trade Ideas — AMEX:KURE - TradingView
Should EM Investors Trim or Retain Their China Exposure?VettaFiCommentaries - Advisor Perspectives
ETFs Investing in Innovent Biologics, Inc. Stocks - TradingView
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Capitalize on China Healthcare Fundraising With KURE - ETF Trends
ETFs Investing in WuXi AppTec Co., Ltd. Class A Stocks - TradingView
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
China Update: New IPOs, Healthcare Momentum, New Hydroelectric Dam - Seeking Alpha
China Thematic Update: New IPOs (KSTR), Healthcare Momentum From Regulatory Reprieve & Innovation (KURE), New Hydroelectric Dam (KGRN) - KraneShares
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Financials Data
There is no financial data for Kraneshares Msci All China Health Care Index Etf (KURE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.53%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):